NDC 50090-6298 – Doxazosin
Doxazosin Mesylate 4 mg/1 · Tablet · Oral
Product NDC50090-6298
Product details
- Brand name
- Doxazosin
- Generic name
- Doxazosin Mesylate
- Labeler
- A-S Medication Solutions
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA209013
- Marketed since
- April 17, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Doxazosin Mesylate 4 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 50090-6298-0 | 30 TABLET in 1 BOTTLE (50090-6298-0) | Dec 29, 2022 |
| 50090-6298-1 | 100 TABLET in 1 BOTTLE (50090-6298-1) | Dec 29, 2022 |
| 50090-6298-2 | 90 TABLET in 1 BOTTLE (50090-6298-2) | Dec 29, 2022 |
Other Doxazosin products
- 50090-2153 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-3143 Doxazosin Mesylate 8 mg/1 · Tablet · A-S Medication Solutions
- 50090-8055 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6401 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-2172 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-5773 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-0701 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-0704 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-3927 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-7803 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
- 16729-414 Doxazosin Mesylate 2 mg/1 · Tablet · Accord Healthcare Inc.
- 16729-211 Doxazosin Mesylate 1 mg/1 · Tablet · Accord Healthcare Inc.